Cargando…

No evidence for relevant impact of renal replacement therapy on clinical effect of erythromycin in critically ill patients with sepsis

Detalles Bibliográficos
Autores principales:	Reijnders, Tom D. Y., Peters-Sengers, Hessel, van der Poll, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948379/ https://www.ncbi.nlm.nih.gov/pubmed/36823610 http://dx.doi.org/10.1186/s13054-023-04359-z

Ejemplares similares

Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation
por: Reijnders, Tom D. Y., et al.
Publicado: (2022)

Association between age and the host response in critically ill patients with sepsis
por: Michels, Erik H. A., et al.
Publicado: (2022)

Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study
por: Peters-Sengers, Hessel, et al.
Publicado: (2021)

Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study
por: Uhel, Fabrice, et al.
Publicado: (2020)

Erythromycin or metoclopramide for feed intolerance in the critically ill
por: Nguyen, N, et al.
Publicado: (2006)

Critical illness gastrointestinal hypomobility disorder and success of enteral erythromycin
por: Shaikh, N, et al.
Publicado: (2009)

Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
por: Honore, Patrick M., et al.
Publicado: (2023)

What Sepsis Researchers Can Learn from COVID-19
por: Schinkel, Michiel, et al.
Publicado: (2021)

Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients
por: de Geus, Hilde R. H., et al.
Publicado: (2010)

Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia
por: van Engelen, Tjitske S. R., et al.
Publicado: (2023)

Correction: Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia
por: van Engelen, Tjitske S. R., et al.
Publicado: (2023)

Robustness of sepsis-3 criteria in critically ill patients
por: Verboom, Diana M., et al.
Publicado: (2019)

Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study
por: Klein Klouwenberg, Peter M. C., et al.
Publicado: (2019)

Regulation and Prognostic Relevance of Symmetric Dimethylarginine Serum Concentrations in Critical Illness and Sepsis
por: Koch, Alexander, et al.
Publicado: (2013)

Fetuin-A, fibroblast growth factor 23 and inflammation in critically ill patients with sepsis
por: Fajol, Abul
Publicado: (2021)

Correction to: Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study
por: Klein Klouwenberg, Peter M. C., et al.
Publicado: (2020)

Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis
por: van Vught, Lonneke A., et al.
Publicado: (2021)

Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward
por: de Brabander, Justin, et al.
Publicado: (2022)

Sepsis: deriving biological meaning and clinical applications from high-dimensional data
por: Schuurman, Alex R., et al.
Publicado: (2021)

Use of dexmedetomidine in critical-ill patients: is it time to look to the actual evidence?
por: Pérez-Nieto, Orlando R., et al.
Publicado: (2023)

Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis
por: Hohlstein, Philipp, et al.
Publicado: (2019)

The leukocyte non-coding RNA landscape in critically ill patients with sepsis
por: Scicluna, Brendon P, et al.
Publicado: (2020)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
por: Saris, Anno, et al.
Publicado: (2021)

Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients
por: Nossent, Esther J., et al.
Publicado: (2021)

Hemophagocytic syndrome in the critically ill
por: Rokyta, R., et al.
Publicado: (2000)

Future of sepsis therapies
por: van der Poll, Tom
Publicado: (2016)

No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness
por: Yasuma, Taro, et al.
Publicado: (2021)

Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis
por: Koch, Alexander, et al.
Publicado: (2010)

Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients
por: van Vught, Lonneke A., et al.
Publicado: (2016)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

Association between delay in intensive care unit admission and the host response in patients with community-acquired pneumonia
por: Pereverzeva, Liza, et al.
Publicado: (2021)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Renal replacement in critically ill patients: the age factor
por: Occhigrossi, F, et al.
Publicado: (2004)

Preemptive renal replacement therapy in critically ill patients?
por: Meersch, Melanie, et al.
Publicado: (2020)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Systemic versus localized coagulation activation contributing to organ failure in critically ill patients
por: Levi, Marcel, et al.
Publicado: (2011)

Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes
por: van Amstel, Rombout B. E., et al.
Publicado: (2023)

The host response in critically ill sepsis patients on statin therapy: a prospective observational study
por: Wiewel, Maryse A., et al.
Publicado: (2018)

Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children
por: Aygün, Fatih, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eb5rqq5cvihpifdasu3flnrsbf